Evidence map›Paper›PMID 32493017›Full record

ArticleBiointerphases2020

Interfacial charge transfer with exfoliated graphene inhibits fibril formation in lysozyme amyloid.

Wren E Gregory, Bipin Sharma, Longyu Hu, Achyut J Raghavendra, Ramakrishna Podila

Open access · greenAbstract read
In one paragraph

Article in Biointerphases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wren E GregoryLaboratory of Nano-Biophysics, Clemson Nanomaterials Institute, Anderson, South Carolina 29625.
Bipin SharmaLaboratory of Nano-Biophysics, Clemson Nanomaterials Institute, Anderson, South Carolina 29625.ORCID 0000000236917676
Longyu HuLaboratory of Nano-Biophysics, Clemson Nanomaterials Institute, Anderson, South Carolina 29625.
Achyut J RaghavendraLaboratory of Nano-Biophysics, Clemson Nanomaterials Institute, Anderson, South Carolina 29625.
Ramakrishna PodilaLaboratory of Nano-Biophysics, Clemson Nanomaterials Institute, Anderson, South Carolina 29625.

Funding

Mechanisms of non-IgE Mast Cell Activation by Environmental ParticulatesR01ES019311 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI BROWN, JARED MICHAEL · 2010 to 2024
$7.0M
NIEHS NIH HHS R01 ES019311
6 · The paper itself

Abstract

Amyloid fibrillation is known to contribute in a variety of diseases including neurodegenerative disorders (e.g., Alzheimer's and Parkinson's disease) and type II diabetes. The inhibition of fibrillation has been suggested as a possible therapeutic strategy to prevent neuronal and pancreatic β-cell death associated with amyloid diseases. To this end, strong hydrophobic and π-π interactions between proteins and nanomaterials at the nanobio interface could be used to mitigate the stacking of amyloid structures associated with fibrillation. In this study, the authors show that exfoliated graphene effectively inhibits the formation of amyloid fibrils using a model amyloid-forming protein, viz., hen egg white lysozyme (HEWL). While previous theoretical models posit that hydrophobic and π-π stacking interactions result in strong interactions between graphene and proteins, the authors experimentally identified the presence of additional interfacial charge transfer interactions between HEWL and graphene using micro-Raman spectroscopy and Kelvin probe force microscopy. Their photoluminescence spectroscopy and transmission electron microscopy studies evince that the interfacial charge transfer combined with hydrophobic and π-π stacking interactions, specifically between the nanomaterial and the amino acid tryptophan, increase HEWL adsorption on graphene and thereby inhibit amyloid fibrillation.

Indexed as

AmyloidAnimalsBenzothiazolesChickensFluorescenceGraphiteMuramidaseProtein Structure, SecondarySpectrum Analysis, RamanAmyloidBenzothiazolesGraphitehen egg lysozymeMuramidasethioflavin T

Identifiers

PMID32493017
PMCPMC7272203
OpenAlexW3032647348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.